SomaLogic Inc (SomaLogic), a subsidiary of Standard BioTools Inc, is a protein biomarker discovery and clinical diagnostics company. It provides SOMAscan assay, a proteomics technology that compares protein levels in individuals with and without various health conditions and identify biological signals of proteins to develop predictive state tests for disease, health and wellness. The company’s SOMAscan assay is based on its slow off-rate modified aptamer (SOMAmer) reagents that comprise a short single-stranded deoxyribonucleic acid (DNA) sequence consisting of protein-like appendages which enable specific binding to a given protein target. It offers its SOMAscan technology available to healthcare researchers for conducting clinical protein measurements and biomarker discovery. SomaLogic is headquartered in Boulder, Colorado, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company SomaLogic Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- SomaLogic Inc Company Overview
- SomaLogic Inc Company Snapshot
- SomaLogic Inc Pipeline Products and Ongoing Clinical Trials Overview
- SomaLogic Inc - Pipeline Analysis Overview
- SomaLogic Inc - Key Facts
- SomaLogic Inc - Major Products and Services
- SomaLogic Inc Pipeline Products by Development Stage
- SomaLogic Inc Ongoing Clinical Trials by Trial Status
- SomaLogic Inc Pipeline Products Overview
- Next-Generation SOMAscan Assay
- Next-Generation SOMAscan Assay Product Overview
- Protein Chip
- Protein Chip Product Overview
- SOMAscan Assay
- SOMAscan Assay Product Overview
- SOMAscan Assay Clinical Trial
- SomaSignal Test - Acute Kidney Injury
- SomaSignal Test - Acute Kidney Injury Product Overview
- SomaSignal Test - Acute Lung Injury
- SomaSignal Test - Acute Lung Injury Product Overview
- SomaSignal Test - Alzheimer's/Dementia Risk
- SomaSignal Test - Alzheimer's/Dementia Risk Product Overview
- SomaSignal Test - Amyotrophic Lateral Sclerosis
- SomaSignal Test - Amyotrophic Lateral Sclerosis Product Overview
- SomaSignal Test - Anticoagulant Adherence
- SomaSignal Test - Anticoagulant Adherence Product Overview
- SomaSignal Test - Breast Cancer
- SomaSignal Test - Breast Cancer Product Overview
- SomaSignal Test - Cardiovascular Risk
- SomaSignal Test - Cardiovascular Risk Product Overview
- SomaSignal Test - Cardiovascular Risk W/ Cancer Chemotox
- SomaSignal Test - Cardiovascular Risk W/ Cancer Chemotox Product Overview
- SomaSignal Test - Cardiovascular Risk W/ COVID
- SomaSignal Test - Cardiovascular Risk W/ COVID Product Overview
- SomaSignal Test - CHF Hospitalization Risk
- SomaSignal Test - CHF Hospitalization Risk Product Overview
- SomaSignal Test - CHF Therapy Sensitivity
- SomaSignal Test - CHF Therapy Sensitivity Product Overview
- SomaSignal Test - Childhood Diseases
- SomaSignal Test - Childhood Diseases Product Overview
- SomaSignal Test - Chronic Kidney Disease Prognosis
- SomaSignal Test - Chronic Kidney Disease Prognosis Product Overview
- SomaSignal Test - Colorectal Cancer
- SomaSignal Test - Colorectal Cancer Product Overview
- SomaSignal Test - Congestive Heart Failure Prognosis
- SomaSignal Test - Congestive Heart Failure Prognosis Product Overview
- SomaSignal Test - COPD Risk
- SomaSignal Test - COPD Risk Product Overview
- SomaSignal Test - Coronary Artery Disease
- SomaSignal Test - Coronary Artery Disease Product Overview
- SomaSignal Test - Diabetic Retinopathy
- SomaSignal Test - Diabetic Retinopathy Product Overview
- SomaSignal Test - Diabetic Status
- SomaSignal Test - Diabetic Status Product Overview
- SomaSignal Test - Duchenne Muscular Dystrophy
- SomaSignal Test - Duchenne Muscular Dystrophy Product Overview
- SomaSignal Test - Endometrial Cancer
- SomaSignal Test - Endometrial Cancer Product Overview
- SomaSignal Test - Hypertension
- SomaSignal Test - Hypertension Product Overview
- SomaSignal Test - Inflammatory Bowel Disease Susceptibility
- SomaSignal Test - Inflammatory Bowel Disease Susceptibility Product Overview
- SomaSignal Test - Kidney Cancer
- SomaSignal Test - Kidney Cancer Product Overview
- SomaSignal Test - Lung Cancer
- SomaSignal Test - Lung Cancer Product Overview
- SomaSignal Test - Lung Cancer Susceptibility
- SomaSignal Test - Lung Cancer Susceptibility Product Overview
- SomaSignal Test - Lymphoma
- SomaSignal Test - Lymphoma Product Overview
- SomaSignal Test - Melanoma
- SomaSignal Test - Melanoma Product Overview
- SomaSignal Test - Mesothelioma
- SomaSignal Test - Mesothelioma Product Overview
- SomaSignal Test - Multiple Sclerosis
- SomaSignal Test - Multiple Sclerosis Product Overview
- SomaSignal Test - Obesity
- SomaSignal Test - Obesity Product Overview
- SomaSignal Test - Ovarian Cancer
- SomaSignal Test - Ovarian Cancer Product Overview
- SomaSignal Test - Pancreatic Cancer
- SomaSignal Test - Pancreatic Cancer Product Overview
- SomaSignal Test - Parkinson's Disease
- SomaSignal Test - Parkinson's Disease Product Overview
- SomaSignal Test - Peripheral Vascular Function
- SomaSignal Test - Peripheral Vascular Function Product Overview
- SomaSignal Test - Preeclampsia
- SomaSignal Test - Preeclampsia Product Overview
- SomaSignal Test - Preterm Labor
- SomaSignal Test - Preterm Labor Product Overview
- SomaSignal Test - Primary Cardiovascular Risk
- SomaSignal Test - Primary Cardiovascular Risk Product Overview
- SomaSignal Test - Primary Cardiovascular Risk Clinical Trial
- SomaSignal Test - Prostate Cancer
- SomaSignal Test - Prostate Cancer Product Overview
- SomaSignal Test - Pulmonary Function
- SomaSignal Test - Pulmonary Function Product Overview
- SomaSignal Test - Rectal Cancer
- SomaSignal Test - Rectal Cancer Product Overview
- SomaSignal Test - Renal Failure With Cardiovascular Diseases
- SomaSignal Test - Renal Failure With Cardiovascular Diseases Product Overview
- SomaSignal Test - Rheumatoid Arthritis
- SomaSignal Test - Rheumatoid Arthritis Product Overview
- SomaSignal Test - Sepsis
- SomaSignal Test - Sepsis Product Overview
- SomaSignal Test - Sleep Apnea
- SomaSignal Test - Sleep Apnea Product Overview
- SomaSignal Test - Statin Adherence
- SomaSignal Test - Statin Adherence Product Overview
- SomaSignal Test - Tuberculosis
- SomaSignal Test - Tuberculosis Product Overview
- SomaLogic Inc - Key Competitors
- SomaLogic Inc - Key Employees
- SomaLogic Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- SomaLogic Inc, Recent Developments
- May 28, 2024: Standard BioTools Purchases the Carterra LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers
- May 02, 2024: Researchers Identify Biomarkers in Blood to Predict Liver Cancer
- Apr 03, 2024: Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan Platform for Translational Medicine Research
- Jan 31, 2024: M42 Launches Proteomics Grant Competition in Collaboration With SomaLogic to Foster Innovative Research in the GCC for the First Time
- Sep 19, 2023: SomaLogic and Korea’s DNA Link partner to bring the 7,000-plex SomaScan platform to the fast-growing Asia-Pacific proteomics market
- Sep 12, 2023: Somalogic Researchers Identify Key Proteins to Aid in Early Detection of Lung, Colon and Breast Cancer and Ovarian Tumors
- Sep 05, 2023: Somalogic Expands Agreement With Novo Nordisk to 2025
- Jul 24, 2023: SomaLogic Partners With Dante Genomics to Enhance Clinical and Research Adoption of Proteomics in Europe
- Jun 12, 2023: SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe
- May 10, 2023: SomaLogic expands into China with groundbreaking Biostar Technology Limited Partnership
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- SomaLogic Inc Pipeline Products and Ongoing Clinical Trials Overview
- SomaLogic Inc Pipeline Products by Equipment Type
- SomaLogic Inc Pipeline Products by Indication
- SomaLogic Inc Ongoing Clinical Trials by Trial Status
- SomaLogic Inc, Key Facts
- SomaLogic Inc, Major Products and Services
- SomaLogic Inc Number of Pipeline Products by Development Stage
- SomaLogic Inc Pipeline Products Summary by Development Stage
- SomaLogic Inc Ongoing Clinical Trials by Trial Status
- SomaLogic Inc Ongoing Clinical Trials Summary
- Next-Generation SOMAscan Assay - Product Status
- Next-Generation SOMAscan Assay - Product Description
- Protein Chip - Product Status
- Protein Chip - Product Description
- SOMAscan Assay - Product Status
- SOMAscan Assay - Product Description
- SOMAscan Assay - Cerebrospinal Fluid-biomarkers-based Diagnostic and Prognostic Models for Multiple Sclerosis
- SOMAscan Assay - Multi-Ethnic Study of Atherosclerosis (MESA)
- SOMAscan Assay - Triangular Phenotyping and Response Assessment in Small Bowel Crohn's Disease Using Magnetic Resonance Enterography (MRE) and Novel Proteomic Biomarkers
- SomaSignal Test - Acute Kidney Injury - Product Status
- SomaSignal Test - Acute Kidney Injury - Product Description
- SomaSignal Test - Acute Lung Injury - Product Status
- SomaSignal Test - Acute Lung Injury - Product Description
- SomaSignal Test - Alzheimer's/Dementia Risk - Product Status
- SomaSignal Test - Alzheimer's/Dementia Risk - Product Description
- SomaSignal Test - Amyotrophic Lateral Sclerosis - Product Status
- SomaSignal Test - Amyotrophic Lateral Sclerosis - Product Description
- SomaSignal Test - Anticoagulant Adherence - Product Status
- SomaSignal Test - Anticoagulant Adherence - Product Description
- SomaSignal Test - Breast Cancer - Product Status
- SomaSignal Test - Breast Cancer - Product Description
- SomaSignal Test - Cardiovascular Risk - Product Status
- SomaSignal Test - Cardiovascular Risk - Product Description
- SomaSignal Test - Cardiovascular Risk W/ Cancer Chemotox - Product Status
- SomaSignal Test - Cardiovascular Risk W/ Cancer Chemotox - Product Description
- SomaSignal Test - Cardiovascular Risk W/ COVID - Product Status
- SomaSignal Test - Cardiovascular Risk W/ COVID - Product Description
- SomaSignal Test - CHF Hospitalization Risk - Product Status
- SomaSignal Test - CHF Hospitalization Risk - Product Description
- SomaSignal Test - CHF Therapy Sensitivity - Product Status
- SomaSignal Test - CHF Therapy Sensitivity - Product Description
- SomaSignal Test - Childhood Diseases - Product Status
- SomaSignal Test - Childhood Diseases - Product Description
- SomaSignal Test - Chronic Kidney Disease Prognosis - Product Status
- SomaSignal Test - Chronic Kidney Disease Prognosis - Product Description
- SomaSignal Test - Colorectal Cancer - Product Status
- SomaSignal Test - Colorectal Cancer - Product Description
- SomaSignal Test - Congestive Heart Failure Prognosis - Product Status
- SomaSignal Test - Congestive Heart Failure Prognosis - Product Description
- SomaSignal Test - COPD Risk - Product Status
- SomaSignal Test - COPD Risk - Product Description
- SomaSignal Test - Coronary Artery Disease - Product Status
- SomaSignal Test - Coronary Artery Disease - Product Description
- SomaSignal Test - Diabetic Retinopathy - Product Status
- SomaSignal Test - Diabetic Retinopathy - Product Description
- SomaSignal Test - Diabetic Status - Product Status
- SomaSignal Test - Diabetic Status - Product Description
- SomaSignal Test - Duchenne Muscular Dystrophy - Product Status
- SomaSignal Test - Duchenne Muscular Dystrophy - Product Description
- SomaSignal Test - Endometrial Cancer - Product Status
- SomaSignal Test - Endometrial Cancer - Product Description
- SomaSignal Test - Hypertension - Product Status
- SomaSignal Test - Hypertension - Product Description
- SomaSignal Test - Inflammatory Bowel Disease Susceptibility - Product Status
- SomaSignal Test - Inflammatory Bowel Disease Susceptibility - Product Description
- SomaSignal Test - Kidney Cancer - Product Status
- SomaSignal Test - Kidney Cancer - Product Description
- SomaSignal Test - Lung Cancer - Product Status
- SomaSignal Test - Lung Cancer - Product Description
- SomaSignal Test - Lung Cancer Susceptibility - Product Status
- SomaSignal Test - Lung Cancer Susceptibility - Product Description
- SomaSignal Test - Lymphoma - Product Status
- SomaSignal Test - Lymphoma - Product Description
- SomaSignal Test - Melanoma - Product Status
- SomaSignal Test - Melanoma - Product Description
- SomaSignal Test - Mesothelioma - Product Status
- SomaSignal Test - Mesothelioma - Product Description
- SomaSignal Test - Multiple Sclerosis - Product Status
- SomaSignal Test - Multiple Sclerosis - Product Description
- SomaSignal Test - Obesity - Product Status
- SomaSignal Test - Obesity - Product Description
- SomaSignal Test - Ovarian Cancer - Product Status
- SomaSignal Test - Ovarian Cancer - Product Description
- SomaSignal Test - Pancreatic Cancer - Product Status
- SomaSignal Test - Pancreatic Cancer - Product Description
- SomaSignal Test - Parkinson's Disease - Product Status
- SomaSignal Test - Parkinson's Disease - Product Description
- SomaSignal Test - Peripheral Vascular Function - Product Status
- SomaSignal Test - Peripheral Vascular Function - Product Description
- SomaSignal Test - Preeclampsia - Product Status
- SomaSignal Test - Preeclampsia - Product Description
- SomaSignal Test - Preterm Labor - Product Status
- SomaSignal Test - Preterm Labor - Product Description
- SomaSignal Test - Primary Cardiovascular Risk - Product Status
- SomaSignal Test - Primary Cardiovascular Risk - Product Description
- SomaSignal Test - Primary Cardiovascular Risk - Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study (SomaSignal Study)
- SomaSignal Test - Prostate Cancer - Product Status
- SomaSignal Test - Prostate Cancer - Product Description
- SomaSignal Test - Pulmonary Function - Product Status
- SomaSignal Test - Pulmonary Function - Product Description
- SomaSignal Test - Rectal Cancer - Product Status
- SomaSignal Test - Rectal Cancer - Product Description
- SomaSignal Test - Renal Failure With Cardiovascular Diseases - Product Status
- SomaSignal Test - Renal Failure With Cardiovascular Diseases - Product Description
- SomaSignal Test - Rheumatoid Arthritis - Product Status
- SomaSignal Test - Rheumatoid Arthritis - Product Description
- SomaSignal Test - Sepsis - Product Status
- SomaSignal Test - Sepsis - Product Description
- SomaSignal Test - Sleep Apnea - Product Status
- SomaSignal Test - Sleep Apnea - Product Description
- SomaSignal Test - Statin Adherence - Product Status
- SomaSignal Test - Statin Adherence - Product Description
- SomaSignal Test - Tuberculosis - Product Status
- SomaSignal Test - Tuberculosis - Product Description
- SomaLogic Inc, Key Employees
- Glossary
- SomaLogic Inc Pipeline Products by Equipment Type
- SomaLogic Inc Pipeline Products by Development Stage
- SomaLogic Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Quotient Biodiagnostics Inc
- Alfa Wassermann Diagnostic Technologies, LLC
- ARK Diagnostics Inc
